MEDICAL CANNABIS

Neurotech poised to commence clinical trials in March quarter

Finfeed Archived Dec 16, 2020

Neurotech International Limited (ASX:NTI) has commenced a stage 1 clinical product formulation and development studies and anticipates entering clinical trials in the March quarter next year.

Changes to OTC cannabis sales just around the corner

Finfeed Archived Nov 26, 2020

The Therapeutic Goods Administration (TGA) will shortly bring down its final decision regarding a major regulatory change in the distribution of cannabidiol (CBD) products in Australia, which could hellp stocks such as Creso Pharma (ASX: CPH).

What does a Kamala Harris Vice Presidency mean for cannabis legalisation?

Finfeed Archived Aug 31, 2020

Joe Biden announced that Kamala Harris is his pick for Vice President, should he win the upcoming US Presidential election in November. But what could a Biden/Harris ticket mean for cannabis legalization?

The world in medical cannabis and weed this week

Finfeed Archived May 01, 2020

The final week in April has proven to be a big week in the cannabis sector, with several global milestones expected in May.

Knee osteoarthritis treatment delivers Regeneus a A$1.6M milestone payment

Finfeed Archived Mar 20, 2020

Regeneus Ltd (ASX: RGS) today received a non-refundable milestone payment of ¥100M (approx. A$1.6M) from Kyocera Corporation (TYO:6971).

CPH Secures Two Execs from the World’s Largest Cannabis Company

Next Investors Archived Mar 11, 2020

ASX Junior Creso Pharma (ASX: CPH) has appointed two former Canopy executives to the senior management team of its wholly-owned Mernova Medical Inc. in Nova Scotia, Canada.

Medical Cannabis